{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T11:32:38Z","timestamp":1771673558527,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ijantimicag.2020.105900","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T11:51:13Z","timestamp":1578657073000},"page":"105900","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Characterisation and risk factor profiling of Pseudomonas aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains"],"prefix":"10.1016","volume":"55","author":[{"given":"Mario","family":"Tumbarello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Raffaelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4640-679X","authenticated-orcid":false,"given":"Maddalena","family":"Peghin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2158-1601","authenticated-orcid":false,"given":"Angela Raffaella","family":"Losito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Chirico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4089-630X","authenticated-orcid":false,"given":"Gabriele","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Spanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assunta","family":"Sartor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Fiori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2020.105900_bib0001","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/1469-0691.12089","article-title":"Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance","volume":"9","author":"Horcajada","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0002","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1017\/ice.2016.174","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011\u20132014","volume":"37","author":"Weiner","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0003","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.46.1800516","article-title":"Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017","volume":"23","author":"Suetens","year":"2018","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0004","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jiph.2009.08.003","article-title":"Urinary tract infections caused by Pseudomonas aeruginosa: a minireview","volume":"2","author":"Mittal","year":"2009","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178178","article-title":"Pseudomonas aeruginosa urinary tract infections in hospitalized patients: mortality and prognostic factors","volume":"12","author":"Lamas Ferreiro","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0006","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Flores-Mireles","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0007","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02671-16","article-title":"Results from a 13-year prospective cohort study show increased mortality associated with bloodstream infections caused by Pseudomonas aeruginosa compared to other bacteria","volume":"61","author":"Thaden","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0008","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.ajic.2013.02.018","article-title":"Nosocomial urinary tract infections caused by Pseudomonas aeruginosa and Acinetobacter species: sensitivity to antibiotics and risk factors","volume":"41","author":"Djordjevic","year":"2013","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0009","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1159\/000358493","article-title":"Antimicrobial susceptibilities and clinical characterization of Pseudomonas aeruginosa isolates from urinary tract infections","volume":"93","author":"Zhang","year":"2014","journal-title":"Urol Int"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0010","series-title":"Surveillance of antimicrobial resistance in Europe. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2017","year":"2018"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0011","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/jac\/dkv043","article-title":"Surveillance of antibiotic susceptibility of urinary tract pathogens for a population of 5.6 million over 4 years","volume":"70","author":"Ironmonger","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0012","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.diagmicrobio.2018.04.012","volume":"92","author":"Sader","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0013","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13756-018-0370-9","article-title":"Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis","volume":"7","author":"Raman","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0014","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2217\/fmb.15.48","article-title":"Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies","volume":"10","author":"El Zowalaty","year":"2015","journal-title":"Future Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0015","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1128\/AAC.00338-07","article-title":"Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection","volume":"51","author":"Lodise","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0016","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1473-3099(17)30228-1","article-title":"Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study","volume":"17","author":"Guti\u00e9rrez-Guti\u00e9rrez","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0017","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/1060028015578259","article-title":"A clinical decision rule identifies risk factors associated with antimicrobial-resistant urinary pathogens in the emergency department: a retrospective validation study","volume":"49","author":"Faine","year":"2015","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0018","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/258517","article-title":"Urinary tract infections due to multidrug-resistant Enterobacteriaceae: prevalence and risk factors in a Chicago emergency department","volume":"2013","author":"Khawcharoenporn","year":"2013","journal-title":"Emerg Med Int"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0019","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12879-015-0974-0","article-title":"An outbreak of multi-drug resistant Escherichia coli urinary tract infection in an elderly population: a case\u2013control study of risk factors","volume":"15","author":"Ikram","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0020","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1177\/0300060514543035","article-title":"Factors associated with specific uropathogens in catheter-associated urinary tract infection: developing a clinical prediction model","volume":"42","author":"Oh","year":"2014","journal-title":"J Int Med Res"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0021","series-title":"CDC\/NHSN surveillance definitions for specific types of infections","year":"2019"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0022","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 9.0, 2019. http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_9.0_Breakpoint_Tables.pdf[accessed 5 July 2019]."},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0023","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0024","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0025","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1111\/j.1469-0691.2011.03686.x","article-title":"Nosocomial urinary tract infection in the intensive care unit: when should Pseudomonas aeruginosa be suspected? Experience of the French national surveillance of nosocomial infections in the intensive care unit, Rea-Raisin","volume":"18","author":"Venier","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0026","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1128\/AAC.02373-13","article-title":"Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae","volume":"58","author":"Tumbarello","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0027","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/AAC.00009-11","article-title":"Identifying patients harboring extended-spectrum-\u03b2-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system","volume":"55","author":"Tumbarello","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0028","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cmi.2017.04.006","article-title":"Colonization by multidrug-resistant organisms in long-term care facilities in Italy: a point-prevalence study","volume":"23","author":"Giufr\u00e8","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0029","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13756-017-0286-9","article-title":"30-Day readmission, antibiotics costs and costs of delay to adequate treatment of Enterobacteriaceae UTI, pneumonia, and sepsis: a retrospective cohort study","volume":"6","author":"Zilberberg","year":"2017","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.ijantimicag.2020.105900_bib0030","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1472-6963-12-122","article-title":"Hospital costs of nosocomial multi-drug resistant Pseudomonas aeruginosa acquisition","volume":"12","author":"Morales","year":"2012","journal-title":"BMC Health Serv Res"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485792030039X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485792030039X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:33:37Z","timestamp":1760376817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485792030039X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S092485792030039X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105900","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterisation and risk factor profiling of Pseudomonas aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105900","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105900"}}